Lancet HIV: The long wait for long-acting HIV prevention and treatment formulations

MSF Access Campaign’s Helen Bygrave and Jessica Burry co-authored this Viewpoint article in the Lancet HIV on improving access to long-acting HIV antiretroviral drugs, for HIV prevention and treatment for people in low- and middle-income countries.